BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 22649440)

  • 1. The pattern, clinical characteristics and outcome of ESRD in Ile-Ife, Nigeria: is there a change in trend?
    Arogundade FA; Sanusi AA; Hassan MO; Akinsola A
    Afr Health Sci; 2011 Dec; 11(4):594-601. PubMed ID: 22649440
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Report from the Caribbean renal registry, 2006.
    Soyibo AK; Barton EN
    West Indian Med J; 2007 Sep; 56(4):355-63. PubMed ID: 18198742
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence and factors affecting peritonitis in CAPD patients in Maharat Nakhon Ratchasima Hospital under universal coverage scheme during 2008-2010: a three-year experience.
    Liawnoraset W
    J Med Assoc Thai; 2011 Sep; 94 Suppl 4():S19-24. PubMed ID: 22043562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [REIN Report 2011--summary].
    Couchoud C; Lassalle M; Jacquelinet C
    Nephrol Ther; 2013 Sep; 9 Suppl 1():S3-6. PubMed ID: 24119584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epidemiological profile of patients with end stage renal disease in a referral hospital in Cameroon.
    Halle MP; Takongue C; Kengne AP; Kaze FF; Ngu KB
    BMC Nephrol; 2015 Apr; 16():59. PubMed ID: 25896605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characteristics and Outcomes of Patients With Systemic Sclerosis (Scleroderma) Requiring Renal Replacement Therapy in Europe: Results From the ERA-EDTA Registry.
    Hruskova Z; Pippias M; Stel VS; Abad-Díez JM; Benítez Sánchez M; Caskey FJ; Collart F; De Meester J; Finne P; Heaf JG; Magaz A; Palsson R; Reisæter AV; Salama AD; Segelmark M; Traynor JP; Massy ZA; Jager KJ; Tesar V
    Am J Kidney Dis; 2019 Feb; 73(2):184-193. PubMed ID: 30122544
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overview: end-stage renal disease in the developing world.
    Barsoum RS
    Artif Organs; 2002 Sep; 26(9):737-46. PubMed ID: 12197924
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of end stage renal disease on renal replacement therapy in Nepal.
    Hada R; Khakurel S; Agrawal RK; Kafle RK; Bajracharya SB; Raut KB
    Kathmandu Univ Med J (KUMJ); 2009; 7(27):301-5. PubMed ID: 20071881
    [TBL] [Abstract][Full Text] [Related]  

  • 9. End-stage renal disease in sub-Saharan and South Africa.
    Naicker S
    Kidney Int Suppl; 2003 Feb; (83):S119-22. PubMed ID: 12864889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal Replacement Therapy in Children in Lithuania: Challenges, Trends, and Outcomes.
    Viršilas E; Čerkauskienė R; Masalskienė J; Rudaitis Š; Dobilienė D; Jankauskienė A
    Medicina (Kaunas); 2018 Nov; 54(5):. PubMed ID: 30400223
    [No Abstract]   [Full Text] [Related]  

  • 11. Impact of initial dialysis modality on the survival of patients with ESRD in eastern China: a propensity-matched study.
    Yao X; Lei W; Shi N; Lin W; Du X; Zhang P; Chen J
    BMC Nephrol; 2020 Jul; 21(1):310. PubMed ID: 32727426
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ten-years trends in renal replacement therapy for end-stage renal disease in mainland France: Lessons from the French Renal Epidemiology and Information Network (REIN) registry.
    Vigneau C; Kolko A; Stengel B; Jacquelinet C; Landais P; Rieu P; Bayat S; Couchoud C;
    Nephrol Ther; 2017 Jun; 13(4):228-235. PubMed ID: 28161264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence and pattern of renal bone disease in end stage renal disease patients in Ile-Ife, Nigeria.
    Sanusi AA; Arogundade FA; Oladigbo M; Ogini LM; Akinsola A
    West Afr J Med; 2010; 29(2):75-80. PubMed ID: 20544630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epidemiology of end-stage renal disease in Dubai: Single-center data.
    Alalawi F; Ahmed M; AlNour H; Noralla M; Alhadari A
    Saudi J Kidney Dis Transpl; 2017; 28(5):1119-1125. PubMed ID: 28937072
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Left ventricular hypertrophy in African Black patients with chronic renal failure at first evaluation.
    Ulasi II; Arodiwe EB; Ijoma CK
    Ethn Dis; 2006; 16(4):859-64. PubMed ID: 17061738
    [TBL] [Abstract][Full Text] [Related]  

  • 16. End-stage renal disease in the El-Minia Governorate, upper Egypt: an epidemiological study.
    El Minshawy O
    Saudi J Kidney Dis Transpl; 2011 Sep; 22(5):1048-54. PubMed ID: 21912050
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcomes of rationing dialysis therapy in biopsy-proven end-stage renal disease in South Africa.
    Okpechi IG; Swanepoel CR; Rayner BL
    J Nephrol; 2012; 25(4):551-7. PubMed ID: 21956769
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The gap between estimated incidence of end-stage renal disease and use of therapy.
    Anand S; Bitton A; Gaziano T
    PLoS One; 2013; 8(8):e72860. PubMed ID: 24023651
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The growing burden of end-stage renal disease in Egypt.
    Soliman AR; Fathy A; Roshd D
    Ren Fail; 2012; 34(4):425-8. PubMed ID: 22260432
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Systemic arterial hypertension in primary chronic glomerulonephritis: prevalence and its influence on the renal prognosis].
    Quirós PL; Ceballos M; Remón C; Hernández Romero MC; Benavides B; Pérez Pérez-Ruilópez MA; Lozano A; Aznar E; Rivero M; Fernández Ruiz E
    Nefrologia; 2005; 25(3):250-7. PubMed ID: 16053006
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.